I like to thank FARMAMONDO TEAM for the exceptional response to my inquiry. Your responsiveness and compassion are clear indication of what FarmaMondo represents and the ethos that you all live by. I have personally dealt with many people in my professional life but the attentiveness that you have provided me is something that I will never forget. You are an exemplary representative of FarmaMondo that many companies should try to emulate.

EUSA and FarmaMondo Group establishes an Emergency Managed Access Program to allow Healthcare Providers to access Siltuximab (Sylvant©) for off label treatment of acute patients of COVID-19

While the world fights through COVID19 pandemic EUSA and Papa Giovani Hospital in Italy had initiated an observational study (SISCO trial — https://clinicaltrials.gov/ct2/show/NCT04322188?term=SISCO&draw=2&rank=1)  on Siltuximab